Opin vísindi

Fletta eftir höfundi "Pazzagli, Laura"

Fletta eftir höfundi "Pazzagli, Laura"

Röðun: Raða: Niðurstöður:

  • Icon
    Antidiabetic medication use during pregnancy: an international utilization study 
    Cesta, Carolyn E; Cohen, Jacqueline M; Pazzagli, Laura; Bateman, Brian T; Bröms, Gabriella; Einarsdottir, Kristjana; Furu, Kari; Havard, Alys; Heino, Anna; Hernandez-Diaz, Sonia; Huybrechts, Krista F; Karlstad, Øystein; Kieler, Helle; Li, Jiong; Leinonen, Maarit K; Gulseth, Hanne L; Tran, Duong; Yu, Yongfu; Zoega, Helga; Odsbu, Ingvild (BMJ, 2019-11-01)
    Objective Diabetes in pregnancy and consequently the need for treatment with antidiabetic medication (ADM) has become increasingly prevalent. The prevalence and patterns of use of ADM in pregnancy from 2006 onward in seven different countries was ...
  • Icon
    Antipsychotic drug use in pregnancy: A multinational study from ten countries 
    Reutfors, Johan; Cesta, Carolyn E.; Cohen, Jacqueline M.; Bateman, Brian T.; Brauer, Ruth; Einarsdóttir, Kristjana; Engeland, Anders; Furu, Kari; Gissler, Mika; Havard, Alys; Hernandez-Diaz, Sonia; Huybrechts, Krista F.; Karlstad, Øystein; Leinonen, Maarit K.; Li, Jiong; Man, Kenneth K.C.; Pazzagli, Laura; Schaffer, Andrea; Schink, Tania; Wang, Zixuan; Yu, Yongfu; Zoega, Helga; Bröms, Gabriella (Elsevier BV, 2020-06)
    Aim: To compare the prevalence and trends of antipsychotic drug use during pregnancy between countries across four continents. Methods: Individually linked health data in Denmark (2000−2012), Finland (2005–2014), Iceland (2004–2017), Norway (2005–2015), ...
  • Icon
    Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy 
    Cesta, Carolyn E.; Rotem, Ran; Bateman, Brian T.; Chodick, Gabriel; Cohen, Jacqueline M.; Furu, Kari; Gissler, Mika; Huybrechts, Krista F.; Kjerpeseth, Lars J.; Leinonen, Maarit K.; Pazzagli, Laura; Zoega, Helga; Seely, Ellen W.; Patorno, Elisabetta; Hernández-Díaz, Sonia (2024-02-05)
    Importance: Increasing use of second-line noninsulin antidiabetic medication (ADM) in pregnant individuals with type 2 diabetes (T2D) may result in fetal exposure, but their teratogenic risk is unknown. Objective: To evaluate periconceptional use of ...